Glycoengineered recombinant alpha1-antitrypsin results in comparable in vitro and in vivo activities to human plasma-derived protein.
Rocamora F, Schoffelen S, Arnsdorf J, Toth EA, Abdul Y, Cleveland TE, Bjørn SP, Min Wu MY, McElvaney NG, Voldborg BGR, et al. 2024. Glycoengineered recombinant alpha1-antitrypsin results in comparable <i>in vitro</i> and <i>in vivo</i> activities to human plasma-derived protein. bioRxiv : the preprint server for biology : . DOI: 10.1101/2024.03.27.587088